We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.52%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$15.6B
AUM Growth
+$1.1B
(+7.6%)
Cap. Flow
-$339M
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
393
New
35
Increased
71
Reduced
176
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$137M |
| 2 |
Amgen
AMGN
|
+$130M |
| 3 |
Ametek
AME
|
+$116M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$92M |
| 5 |
Meta Platforms (Facebook)
META
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$117M |
| 2 |
Pfizer
PFE
|
+$110M |
| 3 |
Nike
NKE
|
+$108M |
| 4 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$86.1M |
| 5 |
Occidental Petroleum
OXY
|
+$74.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.99% |
| 2 | Consumer Discretionary | 15.07% |
| 3 | Industrials | 12.48% |
| 4 | Technology | 12.03% |
| 5 | Communication Services | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNS
201
DELISTED
WNS Holdings
WNS
| $20.7M | 0.13% |
975,001
-195,620
| -17% | -$3.86M |
|
202
XPO
XPO
$23.1B
| $20.6M | 0.13% |
2,747,108
-158,940
| -5% | -$1.23M |
|
203
Lam Research
LRCX
$398B
| $20.1M | 0.13% |
3,919,410
-2,031,650
| -34% | -$9.93M |
|
204
PVH
PVH
$4.09B
| $20M | 0.13% |
168,615
+29,605
| +21% | +$3.8M |
|
205
Matsons
MATX
$6.28B
| $19.8M | 0.13% |
754,757
+139,865
| +23% | +$3.87M |
|
|
JWN
206
DELISTED
Nordstrom
JWN
| $19.7M | 0.13% |
350,555
-146,110
| -29% | -$8.63M |
|
|
DLLR
207
DELISTED
DFC GLOBAL CORP COM STK (DE)
DLLR
| $19.6M | 0.13% |
1,787,613
-103,320
| -5% | -$1.41M |
|
208
MillerKnoll
MLKN
$1.64B
| $19.4M | 0.12% |
663,181
-38,340
| -5% | -$1.06M |
|
209
Cheesecake Factory
CAKE
$5.21B
| $19.2M | 0.12% |
437,289
-20,935
| -5% | -$902K |
|
210
Fortinet
FTNT
$123B
| $19M | 0.12% |
4,686,950
-13,725,750
| -75% | -$55.6M |
|
|
ESV
211
DELISTED
Ensco Rowan plc
ESV
| $18.9M | 0.12% |
88,096
-16,322
| -16% | -$3.74M |
|
212
Celanese
CE
$4.96B
| $18.7M | 0.12% |
354,517
-175,240
| -33% | -$8.58M |
|
|
INXN
213
DELISTED
Interxion Holding N.V.
INXN
| $18.6M | 0.12% |
835,960
+472,340
| +130% | +$11.7M |
|
214
NetApp
NTAP
$37.4B
| $18.6M | 0.12% |
435,505
-248,785
| -36% | -$10.3M |
|
215
QuidelOrtho
QDEL
$1.21B
| $18.6M | 0.12% |
653,246
-176,390
| -21% | -$4.81M |
|
216
BGC Group
BGC
$5.38B
| $17.9M | 0.11% |
4,925,494
-295,730
| -6% | -$1.14M |
|
217
iShares Russell 2000 Growth ETF
IWO
$15B
| $17.6M | 0.11% |
140,004
-75,736
| -35% | -$9.13M |
|
|
IMPV
218
DELISTED
Imperva, Inc.
IMPV
| $17.5M | 0.11% |
+416,910
| New | +$19.9M |
|
219
Albemarle
ALB
$14.2B
| $17.4M | 0.11% |
275,825
-2,895
| -1% | -$182K |
|
|
XXIA
220
DELISTED
Ixia
XXIA
| $16.8M | 0.11% |
1,070,537
+338,720
| +46% | +$5.22M |
|
|
WFT
221
DELISTED
Weatherford International plc
WFT
| $16.7M | 0.11% |
1,089,680
-1,284,430
| -54% | -$18.8M |
|
222
Sensata Technologies
ST
$6.81B
| $15.6M | 0.1% |
+408,610
| New | +$15.3M |
|
|
SWI
223
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $15.6M | 0.1% |
445,270
-123,568
| -22% | -$4.83M |
|
|
SNBR
224
DELISTED
Sleep Number
SNBR
| $15.1M | 0.1% |
+621,200
| New | +$14.9M |
|
|
INVN
225
DELISTED
Invensense Inc
INVN
| $14.6M | 0.09% |
+830,830
| New | +$14M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Westfield Capital Management held 393 positions worth $15.6B, up 7.6% from $14.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q3 2013 filing shows 35 new, 71 increased, 176 reduced and 47 closed positions. Its largest new stake was Amgen: 1,202,551 shares worth $135M. The largest sale was Coca-Cola, an estimated $117M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Westfield Capital Management's largest Q3 2013 buy was Amgen: 1,202,551 shares worth $135M.
- Westfield Capital Management added most to VIROPHARMA INC in Q3 2013, an estimated $137M increase.
- Westfield Capital Management's biggest Q3 2013 reduction was Coca-Cola, cutting an estimated $117M.
- Westfield Capital Management fully exited Nike in Q3 2013, selling an estimated $108M.
- Westfield Capital Management's ten largest holdings make up 16% of its $15.6B portfolio in Q3 2013.
- Westfield Capital Management opened 35 new positions and closed 47 in Q3 2013.
- Westfield Capital Management's portfolio value rose 7.6% quarter-over-quarter to $15.6B.
Based on Westfield Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.